Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (61-70 of 505) with videos related to

Pageof 51
Sort By:
Heart (British Cardiac Society)|February 17, 2001
Images in cardiology: Pneumopyopericardium, complicating penetrating gastric ulcerA S Knudsen, S E Jensen, H Egeblad
The Journal of Biological Chemistry|December 30, 1994
Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of CrkB S Knudsen, S M Feller, H Hanafusa
Cell Cycle (Georgetown, Tex.)|February 26, 2015
The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapyJack Hutcheson, Agnieszka K Witkiewicz, Erik S Knudsen
Oncotarget|August 27, 2014
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancerJorge Franco, Agnieszka K Witkiewicz, Erik S Knudsen
Current Microbiology|June 3, 1998
The effect of the lacY gene on the induction of IPTG inducible promoters, studied in Escherichia coli and Pseudomonas fluorescensL H Hansen, S Knudsen, S J Sørensen
Oncogene|October 17, 1996
The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cellsY Chen, E S Knudsen, J Y Wang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2014
Systematically defining single-gene determinants of response to neoadjuvant chemotherapy reveals specific biomarkersAgnieszka K Witkiewicz, Uthra Balaji, Erik S Knudsen
Genes & Cancer|April 22, 2021
Correction: CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer modelsAgnieszka K Witkiewicz, Derek Cox, Erik S Knudsen
The American Journal of Pathology|January 7, 2014
The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyErik S Knudsen, Purva Gopal, Amit G Singal
The Journal of Surgical Research|July 21, 2007
RB activity alters checkpoint response and chemosensitivity in lung cancer linesMichael F Reed, William A Zagorski, Erik S Knudsen
Pageof 51

Showing results (61-70 of 505) with videos related to

Sort By:
Pageof 51
Heart (British Cardiac Society)|February 17, 2001
Images in cardiology: Pneumopyopericardium, complicating penetrating gastric ulcerA S Knudsen, S E Jensen, H Egeblad
The Journal of Biological Chemistry|December 30, 1994
Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of CrkB S Knudsen, S M Feller, H Hanafusa
Cell Cycle (Georgetown, Tex.)|February 26, 2015
The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapyJack Hutcheson, Agnieszka K Witkiewicz, Erik S Knudsen
Oncotarget|August 27, 2014
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancerJorge Franco, Agnieszka K Witkiewicz, Erik S Knudsen
Current Microbiology|June 3, 1998
The effect of the lacY gene on the induction of IPTG inducible promoters, studied in Escherichia coli and Pseudomonas fluorescensL H Hansen, S Knudsen, S J Sørensen
Oncogene|October 17, 1996
The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cellsY Chen, E S Knudsen, J Y Wang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2014
Systematically defining single-gene determinants of response to neoadjuvant chemotherapy reveals specific biomarkersAgnieszka K Witkiewicz, Uthra Balaji, Erik S Knudsen
Genes & Cancer|April 22, 2021
Correction: CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer modelsAgnieszka K Witkiewicz, Derek Cox, Erik S Knudsen
The American Journal of Pathology|January 7, 2014
The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyErik S Knudsen, Purva Gopal, Amit G Singal
The Journal of Surgical Research|July 21, 2007
RB activity alters checkpoint response and chemosensitivity in lung cancer linesMichael F Reed, William A Zagorski, Erik S Knudsen
Pageof 51